You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 272 No. 13, October 5, 1994 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Caffeine dependence syndrome. Evidence from case histories and experimental evaluations

E. C. Strain, G. K. Mumford, K. Silverman and R. R. Griffiths
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Md 21224.

OBJECTIVE--The extent to which daily caffeine use is associated with a substance dependence syndrome similar to that associated with other psychoactive drugs is unknown. The purpose of this study was to assess volunteers who reported problems with their use of caffeine for evidence suggesting a diagnosis of caffeine dependence based on the generic criteria for substance dependence from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). DESIGN--Case-series evaluations. SETTING--An academic research center. PARTICIPANTS--Self-identified adults who believed they were psychologically or physically dependent on caffeine. MAIN OUTCOME MEASURE--Diagnoses made by a psychiatrist using a structured clinical interview that included a section on caffeine dependence based on genetic criteria for DSM-IV substance dependence. SECONDARY OUTCOME MEASURE--Double-blind caffeine-withdrawal evaluation. RESULTS--Ninety-nine subjects were screened for the study, and 16 were identified as having a diagnosis of caffeine dependence. Median daily caffeine intake was 357 mg, and 19% of subjects consumed less than the national (US) daily average of caffeine. Criteria used for making diagnoses (and rates of their prevalence) were as follows: withdrawal (94%), use continued despite knowledge of a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by caffeine use (94%), persistent desire or unsuccessful efforts to cut down or control use (81%), and tolerance (75%). Eleven subjects underwent the double-blind caffeine-withdrawal evaluation portion of the study, and nine (82%) of the 11 showed objective evidence of caffeine withdrawal, including eight of 11 with functional impairment. CONCLUSIONS--These results, together with other experimental evidence, suggest that caffeine exhibits the features of a typical psychoactive substance of dependence. It is valuable to recognize caffeine dependence as a clinical syndrome, since some people feel compelled to continue caffeine use despite desires and recommendations to the contrary.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuropsychiatric effects of caffeine
Winston et al.
Adv. Psychiatr. Treat. 2005;11:432-439.
ABSTRACT | FULL TEXT  

Caffeine Consumption and Weekly Sleep Patterns in US Seventh-, Eighth-, and Ninth-Graders
Pollak and Bright
Pediatrics 2003;111:42-46.
ABSTRACT | FULL TEXT  

Is Caffeine a Flavoring Agent in Cola Soft Drinks?
Griffiths and Vernotica
Arch Fam Med 2000;9:727-734.
ABSTRACT | FULL TEXT  

Drug Poisoning and Overdose for the Health Professional: Review of Select Over-the-Counter (OTC) and Prescription Medications
Laven and Oller
Journal of Pharmacy Practice 2000;13:37-81.
ABSTRACT  

Caffeine Withdrawal: A Parametric Analysis of Caffeine Dosing Conditions
Evans and Griffiths
J. Pharmacol. Exp. Ther. 1999;289:285-294.
ABSTRACT | FULL TEXT  

Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
Fredholm et al.
Pharmacol. Rev. 1999;51:83-133.
ABSTRACT | FULL TEXT  

Caffeine Intake, Tolerance, and Withdrawal in Women: A Population-Based Twin Study
Kendler and Prescott
Am. J. Psychiatry 1999;156:223-228.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.